Author
Arlan Richardson
- Indexed works
- 28
- Total citations
- 7,568
- Active years
- 14
Collaborators
Works in the record
Cell 2014
Open access · OA
Geroscience: Linking Aging to Chronic Disease
PLoS ONE 2010
Open access · CC-BY
Inhibition of mTOR by Rapamycin Abolishes Cognitive Deficits and Reduces Amyloid-β Levels in a Mouse Model of Alzheimer's Disease
PLoS ONE 2011
Open access · CC-BY
Inducing Autophagy by Rapamycin Before, but Not After, the Formation of Plaques and Tangles Ameliorates Cognitive Deficits
Pharmacology & Therapeutics 2018
Open access · CC-BY
The role of DNA methylation in epigenetics of aging
Aging Cell 2016
Open access · CC-BY
Longer lifespan in male mice treated with a weakly estrogenic agonist, an antioxidant, an α‐glucosidase inhibitor or a Nrf2‐inducer
GeroScience 2020
Open access · CC-BY
Effect of rapamycin on aging and age-related diseases—past and future
The FASEB Journal 2009
Preprint · OA
Increased superoxide <i>in vivo</i> accelerates age‐associated muscle atrophy through mitochondrial dysfunction and neuromuscular junction degeneration
The Journals of Gerontology Series A 2013
Open access · OA
Rapamycin Extends Life and Health in C57BL/6 Mice
Neuroscience 2012
Citation only
Chronic inhibition of mammalian target of rapamycin by rapamycin modulates cognitive and non-cognitive components of behavior throughout lifespan in mice
Aging Cell 2021
Open access · CC-BY
Necroptosis contributes to chronic inflammation and fibrosis in aging liver
Redox Biology 2016
Open access · CC-BY
A new role for oxidative stress in aging: The accelerated aging phenotype in Sod1− mice is correlated to increased cellular senescence
PLoS ONE 2014
Open access · CC-BY
Mice Fed Rapamycin Have an Increase in Lifespan Associated with Major Changes in the Liver Transcriptome
Nucleic Acids Research 2007
Open access · OA
Caloric restriction and genomic stability
Aging Cell 2009
Open access · OA
Lifespan extension in genetically modified mice
The Journals of Gerontology Series A 2013
Open access · OA
Plasma Protein Biomarkers of the Geriatric Syndrome of Frailty
PLoS ONE 2015
Open access · CC-BY
Health Effects of Long-Term Rapamycin Treatment: The Impact on Mouse Health of Enteric Rapamycin Treatment from Four Months of Age throughout Life
Aging 2016
Open access · CC-BY
A cross-sectional study of male and female C57BL/6Nia mice suggests lifespan and healthspan are not necessarily correlated
Science 2012
Preprint · OA
Rapamycin-Induced Insulin Resistance Is Mediated by mTORC2 Loss and Uncoupled from Longevity
Aging 2014
Open access · CC-BY
Rapamycin-induced metabolic defects are reversible in both lean and obese mice
The Journals of Gerontology Series A 2012
Open access · CC-BY
Short-Term Treatment With Rapamycin and Dietary Restriction Have Overlapping and Distinctive Effects in Young Mice
Neurobiology of Aging 2018
Citation only
Caloric restriction mitigates age-associated hippocampal differential CG and non-CG methylation
The Journals of Gerontology Series A 2015
Open access · OA
Preparing for an Aging World: Engaging Biogerontologists, Geriatricians, and the Society
Aging Cell 2018
Open access · CC-BY
Necroptosis increases with age and is reduced by dietary restriction
Aging 2015
Open access · CC-BY
Metabolic consequences of long-term rapamycin exposure on common marmoset monkeys (Callithrix jacchus)
GeroScience 2018
Open access · OA
Simultaneous assessment of cognitive function, circadian rhythm, and spontaneous activity in aging mice
Journal of Clinical Investigation 2013
Open access · OA
Rapamycin, anti-aging, and avoiding the fate of Tithonus
The Journals of Gerontology Series A 2023
Open access · CC-BY
A Genetically Heterogeneous Rat Model with Divergent Mitochondrial Genomes
GeroScience 2024
Open access · CC-BY